These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

578 related items for PubMed ID: 12412782

  • 1. Immunoassays for the detection of parathyroid hormone.
    Jüppner H, Potts JT.
    J Bone Miner Res; 2002 Nov; 17 Suppl 2():N81-6. PubMed ID: 12412782
    [Abstract] [Full Text] [Related]

  • 2. Measurement of parathyroid hormone.
    Endres DB, Villanueva R, Sharp CF, Singer FR.
    Endocrinol Metab Clin North Am; 1989 Sep; 18(3):611-29. PubMed ID: 2673765
    [Abstract] [Full Text] [Related]

  • 3. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L.
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [Abstract] [Full Text] [Related]

  • 4. Immunoassays for parathyroid hormone 1-84 in the diagnosis of hyperparathyroidism.
    Nussbaum SR, Potts JT.
    J Bone Miner Res; 1991 Oct; 6 Suppl 2():S43-50; discussion S61. PubMed ID: 1722383
    [Abstract] [Full Text] [Related]

  • 5. Immunoheterogeneity of parathyroid hormone in venous effluent serum from hyperfunctioning parathyroid glands.
    Flueck JA, Di Bella FP, Edis AJ, Kehrwald JM, Arnaud CD.
    J Clin Invest; 1977 Dec; 60(6):1367-75. PubMed ID: 915003
    [Abstract] [Full Text] [Related]

  • 6. Overproduction of an amino-terminal form of PTH distinct from human PTH(1-84) in a case of severe primary hyperparathyroidism: influence of medical treatment and surgery.
    Räkel A, Brossard JH, Patenaude JV, Albert C, Nassif E, Cantor T, Rousseau L, D'Amour P.
    Clin Endocrinol (Oxf); 2005 Jun; 62(6):721-7. PubMed ID: 15943835
    [Abstract] [Full Text] [Related]

  • 7. New assays for parathyroid hormone (PTH) and the relevance of PTH fragments in renal failure.
    Goodman WG.
    Kidney Int Suppl; 2003 Nov; (87):S120-4. PubMed ID: 14531784
    [Abstract] [Full Text] [Related]

  • 8. Novel parathyroid hormone (1-84) assay as basis for parathyroid hormone monitoring in renal hyperparathyroidism.
    Kaczirek K, Prager G, Riss P, Wunderer G, Asari R, Scheuba C, Bieglmayer C, Niederle B.
    Arch Surg; 2006 Feb; 141(2):129-34; discussion 134. PubMed ID: 16490888
    [Abstract] [Full Text] [Related]

  • 9. The role of quick bio-intact PTH(1-84) assay during parathyroidectomy for secondary hyperparathyroidism.
    Ikeda Y, Kurihara H, Morita N, Miyabe R, Takami H.
    J Surg Res; 2007 Aug; 141(2):306-10. PubMed ID: 17418873
    [Abstract] [Full Text] [Related]

  • 10. Similar predictive value of bone turnover using first- and second-generation immunometric PTH assays in pediatric patients treated with peritoneal dialysis.
    Salusky IB, Goodman WG, Kuizon BD, Lavigne JR, Zahranik RJ, Gales B, Wang HJ, Elashoff RM, Jüppner H.
    Kidney Int; 2003 May; 63(5):1801-8. PubMed ID: 12675856
    [Abstract] [Full Text] [Related]

  • 11. A two-site immunochemiluminometric assay for intact parathyroid hormone and its clinical utility in hemodialysis patients.
    Morita A, Tabata T, Koyama H, Emoto M, Inoue T, Miki T, Nishizawa Y, Morii H.
    Clin Nephrol; 1992 Sep; 38(3):154-7. PubMed ID: 1395169
    [Abstract] [Full Text] [Related]

  • 12. Parathyroid hormone (PTH), PTH-derived peptides, and new PTH assays in renal osteodystrophy.
    Goodman WG, Jüppner H, Salusky IB, Sherrard DJ.
    Kidney Int; 2003 Jan; 63(1):1-11. PubMed ID: 12472763
    [Abstract] [Full Text] [Related]

  • 13. Multicenter evaluation of a new immunoassay for intact PTH measurement on the Elecsys System 2010 and 1010.
    Hermsen D, Franzson L, Hoffmann JP, Isaksson A, Kaufman JM, Leary E, Müller C, Nakatsuka K, Nishizawa Y, Reinauer H, Riesen W, Roth HJ, Steinmüller T, Troch T, Bergmann P.
    Clin Lab; 2002 Jan; 48(3-4):131-41. PubMed ID: 11934215
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Overproduction and secretion of a novel amino-terminal form of parathyroid hormone from a severe type of parathyroid hyperplasia in uremia.
    Arakawa T, D'Amour P, Rousseau L, Brossard JH, Sakai M, Kasumoto H, Igaki N, Goto T, Cantor T, Fukagawa M.
    Clin J Am Soc Nephrol; 2006 May; 1(3):525-31. PubMed ID: 17699255
    [Abstract] [Full Text] [Related]

  • 16. A "carboxyl terminal" clinical radioimmunoassay for parathyroid hormone with apparent recognition preference for the intact hormone.
    Hanley DA, Wellings PG.
    J Immunoassay; 1985 May; 6(3):245-59. PubMed ID: 2413077
    [Abstract] [Full Text] [Related]

  • 17. Development of a novel immunoradiometric assay exclusively for biologically active whole parathyroid hormone 1-84: implications for improvement of accurate assessment of parathyroid function.
    Gao P, Scheibel S, D'Amour P, John MR, Rao SD, Schmidt-Gayk H, Cantor TL.
    J Bone Miner Res; 2001 Apr; 16(4):605-14. PubMed ID: 11315988
    [Abstract] [Full Text] [Related]

  • 18. Clinical utility of an immunoradiometric assay for parathyroid hormone (1-84) in primary hyperparathyroidism.
    Silverberg SJ, Gao P, Brown I, LoGerfo P, Cantor TL, Bilezikian JP.
    J Clin Endocrinol Metab; 2003 Oct; 88(10):4725-30. PubMed ID: 14557447
    [Abstract] [Full Text] [Related]

  • 19. Immunoreactivity of human parathyroid hormone (28-48): attempt to develop an assay for intact human parathyroid hormone.
    Mallette LE.
    Metab Bone Dis Relat Res; 1983 Oct; 4(6):329-32. PubMed ID: 6664305
    [Abstract] [Full Text] [Related]

  • 20. The influence of parathyroid hormone and its fragments on results from midregion and C-terminal specific radioimmunoassays.
    Kübler N, Krause U, Wagner PK, Beyer J, Rothmund M.
    Exp Clin Endocrinol; 1987 Mar; 89(1):61-9. PubMed ID: 3595732
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.